Search

Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.

… Monday, June 27, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its

Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK).

… Monday, October 4, 2021 Deb Schrag, MD, MPH, has been named the new Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center (MSK). An accomplished healthcare leader, clinician, researcher, and expert in public health and population science, Dr. Schrag has a deep familiarity with

Remembering Kathryn Anderson, the founding chair of the Developmental Biology Program in the Sloan Kettering Institute.

… Monday, March 1, 2021 Summary Kathryn Anderson, the founding Chair of the Developmental Biology Program in the Sloan Kettering Institute, died in November 2020. Here, some of her colleagues remember her generous spirit and contributions to women in science. Kathryn Anderson was once asked to explain

Learn about the MSK Healthy Living program that provides breast cancer patients with a custom plan tailored to their needs to help with nutrition and exercise, integrative medicine; support for mental, emotional, and spiritual well-being and much more.

… Thursday, September 28, 2023 Marcia McFayden, a retired elementary school computer teacher, came to Memorial Sloan Kettering Cancer Center (MSK) determined to recover her health when she was diagnosed with stage 1 breast cancer . During her successful treatment, Marcia also set a new goal for herself

Learn how to make guests with cancer feel welcome and included at the table this holiday season.

… Monday, November 22, 2021 Holidays are all about traditions, and food is at the center of many of them. For people with cancer, though, hearty holiday foods may be hard to enjoy because cancer treatments can sometimes cause poor appetite , nausea , and additional side effects. But holiday hosts can stay

The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.

… Monday, July 27, 2020 The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD . He will be presenting, “A Cell-Extrinsic Mechanism Limiting Immunity and Inflammation.” Dr. Rudensky is an internationally

Memorial Sloan Kettering Cancer Center (MSK) announces its most recent awards and appointments for the institution’s physicians, scientists, nurses, and staff.

… Monday, June 15, 2020 Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments: Design and Construction of David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center Recognized by Industry Leaders David H. Koch Center for Cancer Care at Memorial

Researchers are developing uses for a drug that could benefit many people with lung cancer.

… Tuesday, March 15, 2016 Summary Although some lung cancer patients have benefited from developments in precision therapy, those with mutations in a gene called KRAS have not. Now MSK researchers are developing uses for a compound that targets a common KRAS mutation in lung cancer. Highlights KRAS has

Go behind the scenes with Filemon Dela Cruz, who cares for children with sarcoma and conducts precision medicine research at Memorial Sloan Kettering.

… Monday, September 17, 2018 Summary Precision oncology is based on the idea that people can be treated according to the genetic changes that cause a tumor to grow and spread. At Memorial Sloan Kettering, this area of medicine is helping both children and adults. Here, pediatric sarcoma specialist Filemon

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.

… Monday, September 9, 2013 Summary Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable. A new international study led by physicians and scientists from Memorial Sloan Kettering has discovered a gene mutation linked